Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9

References

• Shimizu M, Furuichi K, Wada T. Epidemiology and pathogenesis of diabetic nephropathy. Nihon Jinzo Gakkai Shi. 2017;59(2):43–49.
   PubMedGoogle Scholar
• Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884–895.
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond)). 2013;124(3):139–152.
   PubMed Web of Science ®Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–1070.
   PubMed Web of Science ®Google Scholar
• Tung C-W, Hsu Y-C, Shih Y-H, et al. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology. 2018;23 Suppl 4:32–37.
   PubMed Web of Science ®Google Scholar
• Dai H, Liu Q, Liu B. Research progress on mechanism of podocyte depletion in diabetic nephropathy. J Diabetes Res. 2017;2017:2615286.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Song W, Fu T. Circular RNA-associated competing endogenous RNA network and prognostic nomogram for patients with colorectal cancer. Front Oncol. 2019;9:1181.
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Sun HS, Tsai SJ. Circular RNA – new member of noncoding RNA with novel functions. Exp Biol Med (Maywood)). 2017;242(11):1136–1141.
   PubMed Web of Science ®Google Scholar
• Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31–44.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhou Y, Liang G, et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019;10(2):55.
   PubMed Web of Science ®Google Scholar
• Wu F, Han B, Wu S, et al. Circular RNA TLK1 aggravates neuronal injury and neurological deficits after ischemic stroke via miR-335-3p/TIPARP. J Neurosci. 2019;39(37):7369–7393.
   PubMed Web of Science ®Google Scholar
• Peng F, Gong W, Li S, et al. circRNA_010383 acts as a sponge for miR-135a and its downregulated expression contributes to renal fibrosis in diabetic nephropathy. Diabetes. 2020;70:db200203.
   Web of Science ®Google Scholar
• Yao T, Zha D, Hu C, et al. Circ_0000285 promotes podocyte injury through sponging miR-654-3p and activating MAPK6 in diabetic nephropathy. Gene. 2020;747:144661.
   PubMed Web of Science ®Google Scholar
• Wang Q, Cang Z, Shen L, et al. Circ_0037128/miR-17-3p/AKT3 axis promotes the development of diabetic nephropathy. Gene. 2021;765:145076.
   PubMed Web of Science ®Google Scholar
• Zhong S, Wang J, Zhang Q, et al. CircPrimer: a software for annotating circRNAs and determining the specificity of circRNA primers. BMC Bioinform. 2018;19(1):292.
   PubMed Web of Science ®Google Scholar
• Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes Metab Res Rev. 2017;33(2):e2841.
   Web of Science ®Google Scholar
• Krolewski AS, Skupien J, Rossing P, et al. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int. 2017;91(6):1300–1311.
   PubMed Web of Science ®Google Scholar
• Yang H, Xie T, Li D, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Mol Metab. 2019;23:24–36.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wan J, Hou X, et al. MicroRNA-27a promotes podocyte injury via PPARgamma-mediated beta-catenin activation in diabetic nephropathy. Cell Death Dis. 2017;8(3):e2658–e2658.
   PubMedGoogle Scholar
• Peng H, Wang L, Su Q, et al. MiR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB. Biomed Pharmacother. 2019;109:208–216.
   PubMed Web of Science ®Google Scholar
• Lu Z, He Q, Liang J, et al. miR-31-5p is a potential circulating biomarker and therapeutic target for oral cancer. Mol Ther Nucleic Acids. 2019;16:471–480.
   PubMedGoogle Scholar
• Bi J, Liu H, Cai Z, et al. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis. Aging. 2018;10(8):1964–1976.
   PubMedGoogle Scholar
• Li Y, Quan J, Chen F, et al. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1). Biomed Pharmacother. 2019;111:517–526.
   PubMed Web of Science ®Google Scholar
• Luo J, Li L, Hu D, et al. LINC00612/miR-31-5p/Notch1 axis regulates apoptosis, inflammation, and oxidative stress in human pulmonary microvascular endothelial cells induced by cigarette smoke extract. Int J Chron Obstruct Pulmon Dis. 2020;15:2049–2060.
   PubMed Web of Science ®Google Scholar
• Rovira-Llopis S, Escribano-Lopez I, Diaz-Morales N, et al. Downregulation of miR-31 in diabetic nephropathy and its relationship with inflammation. Cell Physiol Biochem. 2018;50(3):1005–1014.
   PubMedGoogle Scholar
• Simmen RCM, Pabona JMP, Velarde MC, et al. The emerging role of Krüppel-like factors in endocrine-responsive cancers of female reproductive tissues. J Endocrinol. 2010;204(3):223–231.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun Q, Jiang M, et al. KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28. Faseb J. 2019;33(7):7915–7928.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Zhou F, Wang D, et al. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines. Oncol Rep. 2018;40(6):3852–3860.
   PubMed Web of Science ®Google Scholar
• He Q, Huang L, Yan D, et al. CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9. Aging. 2019;11(23):11314–11328.
   PubMedGoogle Scholar
• Yan Q, He B, Hao G, et al. KLF9 aggravates ischemic injury in cardiomyocytes through augmenting oxidative stress. Life Sci. 2019;233:116641.
   PubMed Web of Science ®Google Scholar
• Cui A, Fan H, Zhang Y, et al. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia . J Clin Invest. 2019;129(6):2266–2278.
   PubMed Web of Science ®Google Scholar
• He X, Zeng X. LncRNA SNHG16 aggravates high glucose-induced podocytes injury in diabetic nephropathy through targeting miR-106a and thereby up-regulating KLF9. Diabetes Metab Syndr Obes. 2020;13:3551–3560.
   PubMed Web of Science ®Google Scholar